Trial Profile
To examine the effects of aging and comorbidity on the choice of initial disease modifying treatment in patients with Multiple Sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Nov 2016
Price :
$35
*
At a glance
- Drugs Glatiramer acetate (Primary) ; Interferon beta-1a; Interferon beta-1b
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 21 Nov 2016 New trial record